Suven Life Sciences Ltd. — Share Issue/Capital Change 2026

May 13, 2026

S

SUVEN

Life Sciences

CSD/NSE&BSE/ESOP/2026-27

Date: May 13, 2026

To

The Department of Corporate Services

BSE Limited

25th Floor, P. J. Towers,

Dalal Street, Mumbai - 400001

Scrip Code: 530239

To

The Listing Department

National Stock Exchange of India Limited

Exchange Plaza, Bandra Kurla Complex

Bandra (E), Mumbai – 400051

Scrip Symbol: SUVEN

Dear Sir/Madam,

Sub: Grant of Stock Options by the Nomination & Remuneration Committee of the Company

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Nomination & Remuneration Committee of the Suven Life Sciences Limited (“Company”) considered and approved the Grant-III of 1,33,200 Stock Options at its meeting held on 13th May, 2026 under the Suven Life Sciences Limited – Employee Stock Option Scheme 2020 (“SLSL ESOP 2020”) to the eligible employees of the Company.

The required information in compliance with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, is enclosed herewith as Annexure – 1

This is for your information and records.

Thanking you,

Yours faithfully,

For Suven Life Sciences Limited

Kandari

Sangeetha

Laxmi

Digitally signed by

Kandari Sangeetha Laxmi

Date: 2026.05.13 13:42:32

+05'30'

K. Sangeetha Laxmi

Company Secretary and Compliance officer

Encl.: as above

Suven Life Sciences Limited

Registered Office: 8-2-334 | SDE Serene Chambers | 6th Floor Road No.5 | Avenue 7

Banjara Hills | Hyderabad – 500 034 | Telangana | India | CIN: L24110TG1989PLC009713

Tel: 91 40 2354 1142/ 1152 Email: info@suven.com website: www.suven.com

---

SUVEN
Life Sciences

Annexure 1

Sl. No.	Items of Disclosure	Description
1.	Brief details of options granted	Grant-III: 1,33,200 Stock Options have been granted to the eligible employees of the Company, under the Scheme-“Suven Life Employee Stock Option Scheme 2020 (SLSL ESOP 2020)”.
2.	whether the scheme is in terms of SEBI (SBEB) Regulations, 2021 (if applicable)	Yes
3.	total number of shares covered by these options	1,33,200 Equity shares of ₹ 1/- each of the Company. Each stock option carries the right to apply for and be allotted 1 (one) equity share of face value of ₹ 1/- each of the Company.
4.	pricing formula	The exercise price of each ESOP shall be ₹ 55/- per option
5.	options vested	All the options granted shall vest not earlier than minimum period of 1 (one) year.
Vesting schedule to be as follows:
		1st Tranche	40% of options granted	13-May-2027
		2nd Tranche	30% of options granted	13-May-2028
		3rd Tranche	30% of options granted	13-May-2029
		The Nomination and Remuneration Committee may at its discretion, but subject to applicable laws, change the vesting schedule provided that such change is not detrimental in the interest of the employees.
6.	time within which option may be exercised	The exercise period shall be up to two (2) years from the date of vesting of Options.
7.	options exercised	Nil
8.	money realized by exercise of options	Nil
9.	the total number of shares arising as a result of exercise of option	Nil
10.	options lapsed	Nil
11.	variation of terms of options	The Board or Nomination and Remuneration Committee may, if it deems necessary, modify, change, vary, amend, suspend or terminate the SLSL ESOP 2020, subject to compliance with the applicable laws and regulations.
12.	brief details of significant terms	Options granted under SLSL ESOP 2020 shall vest not earlier than minimum period of 1 (One) year.
13.	subsequent changes or cancellation or exercise of such options	NA
14.	diluted earnings per share pursuant to issue of equity shares on exercise of options	NA

Suven Life Sciences Limited
Registered Office: 8-2-334 | SDE Serene Chambers | 6th Floor Road No.5 | Avenue 7
Banjara Hills | Hyderabad – 500 034 | Telangana | India | CIN: L24110TG1989PLC009713
Tel: 91 40 2354 1142/ 1152 Email: info@suven.com website: www.suven.com